4 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 4 |
Follow Prevention: new trials by email Literature Review of Prevention trials Research Report on Prevention
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MI and PreviDent Varnish on Non Cavitated Interproximal Lesions. MI Varnish, PreviDent Varnish, 1.23% APF - Prevention | Phase 4 | Unknown | King Abdulaziz University | 90 | 2019-01-01 | 2020-04-09 |
| Study on Pressure Ulcers Prevention With Mepilex® Border Sacrum Dressing in Scheduled Cardiovascular Surgery Mepilex® Border dressing, Standard care - Pressure Ulcers, Prevention | Phase 4 | Unknown | University Hospital, Clermont-Ferrand | 478 | 2018-12-10 | 2019-01-31 |
| Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users High dose Atorvastatin+enoxaparin, Enoxaparin - Thrombosis, Prevention | Phase 4 | Unknown | Hallym University Medical Center | 180 | 2009-11-01 | 2010-02-05 |
| Rosuvastatin for Preventing Deep Vein Thrombosis Rosuvastatin 20mg/d for 14days, enoxaparin only - Deep Vein Thrombosis, Venous | Phase 4 | Unknown | Hallym University Medical Center | 180 | 2009-10-01 | 2011-10-05 |
Thrombosis (2) · Pressure Ulcer (1) · Skin Ulcer (1) · Ulcer (1) · Venous Thrombosis (1)
Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Vascular Diseases (2) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Enoxaparin (1) · Rosuvastatin Calcium (1) · Standard of Care (1) · casein phosphopeptide-amorphous calcium phosphate nanocomplex (1)
Hallym University Medical Center (2) · King Abdulaziz University (1) · University Hospital, Clermont-Ferrand (1)
South Korea (2) · France (1) · Saudi Arabia (1)
Sang-Ho Jo, MD (2) · Heba J Sabbagh, PHD (1) · Young-Jin Choi, MD (1)